Page last updated: 2024-10-24

interleukin-8 binding

Definition

Target type: molecularfunction

Binding to interleukin-8. [GOC:jl]

Interleukin-8 (IL-8), also known as CXCL8, is a chemokine primarily involved in the recruitment and activation of neutrophils, a type of white blood cell. It exerts its effects by binding to two specific G protein-coupled receptors (GPCRs) on the surface of target cells: CXCR1 and CXCR2. These receptors belong to the rhodopsin-like family of GPCRs, characterized by a seven-transmembrane domain structure. Upon binding to IL-8, these receptors activate intracellular signaling pathways, leading to a cascade of events culminating in neutrophil chemotaxis, activation, and degranulation. The binding of IL-8 to its receptors initiates a conformational change in the receptor, allowing the activation of heterotrimeric G proteins. These G proteins are composed of alpha, beta, and gamma subunits, and the alpha subunit is responsible for mediating downstream signaling events. Specifically, the activated alpha subunit dissociates from the beta and gamma subunits, and can then activate other intracellular signaling molecules, such as phospholipase C (PLC). PLC hydrolyzes phosphatidylinositol 4,5-bisphosphate (PIP2) into diacylglycerol (DAG) and inositol trisphosphate (IP3). DAG activates protein kinase C (PKC), while IP3 triggers the release of calcium ions from intracellular stores. The increase in intracellular calcium levels and the activation of PKC further contribute to the recruitment and activation of neutrophils. IL-8 binding also activates mitogen-activated protein kinases (MAPKs) and other signaling pathways, leading to the production of inflammatory mediators and the expression of adhesion molecules on the surface of neutrophils. These events facilitate the migration of neutrophils towards the site of inflammation and their interaction with the endothelium. Overall, IL-8 binding to its receptors on neutrophils plays a crucial role in the initiation and amplification of the inflammatory response by promoting neutrophil chemotaxis, activation, and degranulation, thus contributing to the defense against infections and tissue repair.'
"

Proteins (2)

ProteinDefinitionTaxonomy
C-X-C chemokine receptor type 2A C-X-C chemokine receptor type 2 that is encoded in the genome of human. [PRO:WCB, UniProtKB:P25025]Homo sapiens (human)
C-X-C chemokine receptor type 1A C-X-C chemokine receptor type 1 that is encoded in the genome of human. [PRO:WCB, UniProtKB:P25024]Homo sapiens (human)

Compounds (18)

CompoundDefinitionClassesRoles
clotrimazoleconazole antifungal drug;
imidazole antifungal drug;
imidazoles;
monochlorobenzenes
antiinfective agent;
environmental contaminant;
xenobiotic
diclofenacdiclofenac : A monocarboxylic acid consisting of phenylacetic acid having a (2,6-dichlorophenyl)amino group at the 2-position.

Diclofenac: A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt.
amino acid;
aromatic amine;
dichlorobenzene;
monocarboxylic acid;
secondary amino compound
antipyretic;
drug allergen;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
environmental contaminant;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
xenobiotic
disulfiramorganic disulfide;
organosulfur acaricide
angiogenesis inhibitor;
antineoplastic agent;
apoptosis inducer;
EC 1.2.1.3 [aldehyde dehydrogenase (NAD(+))] inhibitor;
EC 3.1.1.1 (carboxylesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
EC 5.99.1.2 (DNA topoisomerase) inhibitor;
ferroptosis inducer;
fungicide;
NF-kappaB inhibitor
itraconazolepiperazines
dexibuprofendexibuprofen: structure in first sourceibuprofennon-narcotic analgesic;
non-steroidal anti-inflammatory drug
ibuprofen, (r)-isomeribuprofen
ketoprofen
dexketoprofendexketoprofen : A monocarboxylic acid that is (S)-hydratropic acid substituted at position 3 on the phenyl ring by a benzoyl group. A cyclooxygenase inhibitor, it is used to relieve short-term pain, such as muscular pain, dental pain and dysmenorrhoea.benzophenones;
monocarboxylic acid
cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug
sb 225002nitrophenol
quercetin7-hydroxyflavonol;
pentahydroxyflavone
antibacterial agent;
antineoplastic agent;
antioxidant;
Aurora kinase inhibitor;
chelator;
EC 1.10.99.2 [ribosyldihydronicotinamide dehydrogenase (quinone)] inhibitor;
geroprotector;
phytoestrogen;
plant metabolite;
protein kinase inhibitor;
radical scavenger
reparixinreparixin: inhibits CXCR1 to prevent polymorphonuclear cell recruitmentmonoterpenoid
sb 265610
sch 527123
sb 656933
amd 070mavorixafor: a derivative of AMD3100; a CXCR4 blockeraminoquinoline
azd8309AZD8309: CXCR2 inhibitor
a 803467A 803467: an Nav1.8 sodium channel blocker; structure in first source
gsk1325756danirixin: structure in first source